VAMP2 Protein

VAMP2 Protein

Introduction

VAMP2 (Vesicle-Associated Membrane Protein 2), also known as Synaptobrevin-2 (Syb2), is the neuronal isoform of the synaptobrevin protein and serves as the primary v-SNARE (vesicle SNAP receptor) in the synaptic vesicle fusion machinery. Together with [SNAP-25](/proteins/snap25) and [syntaxin-1](/proteins/stx1a-protein), VAMP2 forms the core SNARE complex that drives Ca²⁺-triggered synaptic vesicle exocytosis. VAMP2 is essential for fast synchronous neurotransmitter release, and its dysfunction is implicated in Alzheimer's disease, Parkinson's disease, and neurodevelopmental disorders.

VAMP2 Protein

Introduction

VAMP2 (Vesicle-Associated Membrane Protein 2), also known as Synaptobrevin-2 (Syb2), is the neuronal isoform of the synaptobrevin protein and serves as the primary v-SNARE (vesicle SNAP receptor) in the synaptic vesicle fusion machinery. Together with [SNAP-25](/proteins/snap25) and [syntaxin-1](/proteins/stx1a-protein), VAMP2 forms the core SNARE complex that drives Ca²⁺-triggered synaptic vesicle exocytosis. VAMP2 is essential for fast synchronous neurotransmitter release, and its dysfunction is implicated in Alzheimer's disease, Parkinson's disease, and neurodevelopmental disorders.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">VAMP2 Protein Overview</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Vesicle-Associated Membrane Protein 2 (Synaptobrevin-2)</td></tr>
<tr><td><strong>Gene</strong></td><td>VAMP2</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P63027" target="_blank">P63027</a></td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>17p13.1</td></tr>
<tr><td><strong>PDB Structures</strong></td><td>1KA7, 1K5N, 2QNO, 5W5D, 6Y1P</td></td>
<tr><td><strong>Molecular Weight</strong></td><td>~12.7 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Synaptic vesicle membrane, presynaptic active zone</td></tr>
<tr><td><strong>Protein Family</strong></td><td>VAMP/synaptobrevin family (2 isoforms: VAMP1, VAMP2)</td></tr>
<tr><td><strong>Tissue Distribution</strong></td><td>Brain (highest in hippocampus, cortex, cerebellum), endocrine cells</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a>, <a href="/wiki/neurodegeneration" style="color:#ef9a9a">Neurodegeneration</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">23 edges</a></td>
</tr>
</table>
</div>

Structure

VAMP2 is a small type IV membrane protein with a simple architecture optimized for its role in synaptic vesicle fusion[@sutton1998]:

Primary Structural Features

• N-terminal region (residues 1-60): Proline-rich, highly flexible cytoplasmic domain containing the SNARE motif
• SNARE motif (residues 28-84): The 60-residue α-helical region that forms the core of the SNARE complex. Contains the invariant Arginine (R) residue at position 50 — the "0 layer" that pairs with Glutamine (Q) residues from [SNAP-25](/proteins/snap25) and [syntaxin-1](/proteins/stx1a-protein)
• Transmembrane domain (residues 96-116): C-terminal transmembrane helix anchoring the protein to the synaptic vesicle membrane
• C-terminal tail (residues 116-118): Short luminal segment following the transmembrane anchor

Comparison with VAMP Family Members

| Feature | VAMP2 (Synaptobrevin-2) | VAMP1 (Synaptobrevin-1) | VAMP3 (Cellubrevin) |
|---------|------------------------|------------------------|---------------------|
| Primary expression | Neurons, neuroendocrine | Muscle, neurons | Ubiquitous |
| Synaptic function | Core v-SNARE | Peripheral nervous system | General trafficking |
| Knockout phenotype | Severely impaired release | Compensates partially | Compensates |
| Disease relevance | AD, PD, neurodevelopmental | Myasthenic syndrome | Less characterized |

SNARE Complex Participation

VAMP2 is the paradigmatic v-SNARE (vesicular SNARE):

Normal Function

Synaptic Vesicle Exocytosis

VAMP2 is the essential v-SNARE for neurotransmitter release[@sudukum1998]:

Vesicle Docking and Priming

• VAMP2 on synaptic vesicles interacts with syntaxin-1A and SNAP-25 at the presynaptic active zone
• The trans-SNARE complex assembles in a stepwise manner starting with VAMP2-syntaxin-1
• Priming converts vesicles into a release-ready state

• Action potentials depolarize the presynaptic terminal
• Voltage-gated Ca²⁺ channels open, raising local [Ca²⁺] to ~100 μM
• [Synaptotagmin-1](/proteins/syt1-protein) (the Ca²⁺ sensor) binds Ca²⁺ and interacts with the SNARE complex
• SNARE zippering drives fusion pore opening and neurotransmitter release

• VAMP2 knockout mice die shortly after birth
• Central synapses show near-complete loss of fast synchronous release
• Asynchronous and spontaneous release are partially preserved
• Synaptic vesicle pools are normal but fusion is blocked[@sudukum1998]

SNARE Complex Assembly

VAMP2 participates in the formation of the core SNARE complex[@sutton1998]:

| Complex | Components | State |
|---------|------------|-------|
| Binary R-SNARE | VAMP2 + Syntaxin-1 | Partially zippered, Ca²⁺-sensitive |
| Ternary SNARE | VAMP2 + SNAP-25 + Syntaxin-1 | Fully assembled, fusion-competent |
| Post-fusion | Disassembled by NSF/α-SNAP | Components recycled |

Vesicle Recycling

After exocytosis, VAMP2 is retrieved via clathrin-mediated endocytosis[@fdez2014]:

• Dynamin (assisted by dynamin-1 and dynamin-3) pinches off vesicles at the active zone
• Synaptojanin-1 (a phosphoinositide phosphatase) removes phosphoinositides from the vesicle membrane
• VAMP2 returns to the synaptic vesicle pool for another round of release
• Efficient recycling is essential for sustained neurotransmitter release during high-frequency stimulation

Autophagy and Endolysosomal Pathways

VAMP2 participates in autophagosome-lysosome fusion[@lin2017]:

• VAMP2 on autophagosomes pairs with syntaxin-17 (a different syntaxin isoform)
• This heterodimeric SNARE complex mediates autophagosome-lysosome fusion
• The SNARE complex is reactivated by the ATPase NSF after fusion
• Impaired VAMP2 function disrupts autophagic flux, contributing to protein aggregate accumulation

Role in Neurodegenerative Diseases

Alzheimer's Disease

VAMP2 dysfunction contributes to synaptic failure in AD[@diaz2023]:

Synaptic Vesicle Depletion

• Post-mortem AD hippocampus shows reduced VAMP2 protein levels
• This correlates with cognitive decline scores and Braak staging
• Loss of VAMP2 reflects depletion of functional synaptic vesicles

• [Aβ oligomers](/proteins/amyloid-beta) impair VAMP2-SNAP-25 interactions in lipid mixing assays
• Aβ treatment reduces VAMP2Syntaxin-1 binary complex stability
• Disruption of the v-SNARE contributes to impaired synchronous release
• Synaptic vesicles become "reluctant" to fuse, reducing release probability

• Electrophysiology in AD mouse models shows reduced EPSC amplitude
• VAMP2 recycling is impaired during repetitive stimulation
• These deficits precede measurable synapse loss

Parkinson's Disease

VAMP2 is directly implicated in PD pathogenesis through [alpha-synuclein](/proteins/alpha-synuclein) interactions[@burre2010]:

Alpha-Synuclein Inhibition of SNARE Assembly

• α-Synuclein binds VAMP2 via its C-terminal region
• This interaction prevents VAMP2 from engaging with syntaxin-1 and SNAP-25
• Result: reduced SNARE complex formation and impaired vesicle fusion
• Overexpression of α-Syn reduces VAMP2 mobility at the active zone

• Rare VAMP2 variants have been identified in familial PD cohorts[@bhalla2021]
• These variants may affect VAMP2-SNARE interactions or trafficking
• However, VAMP2 is not a major causal gene — most PD is driven by α-Syn, LRRK2, GBA, and other factors

• VAMP2 is essential for dopamine release from striatal terminals
• Impaired VAMP2 function contributes to the dopamine deficit in PD
• Restoring SNARE complex assembly improves dopamine release in model systems

• Overexpressing VAMP2 rescues synaptic transmission in α-Syn transgenic mice
• Enhancing SNARE complex stability is a therapeutic strategy for PD
• Small molecules that stabilize the VAMP2-SNARE interaction are in development

Neurodevelopmental Disorders

VAMP2 variants cause a neurodevelopmental syndrome distinct from neurodegeneration[@diaz2022]:

Clinical Phenotype

• De novo VAMP2 variants cause intellectual disability, seizures, and movement abnormalities
• Features include developmental delay, hypotonia, and autism spectrum traits
• The disorder mirrors the VAMP2 knockout phenotype in mice

• Haploinsufficiency reduces synaptic vesicle fusion probability
• Impaired SNARE complex assembly affects short-term plasticity
• Neuronal morphology is altered with reduced dendritic arborization

• Neurodevelopmental VAMP2 disease involves loss-of-function
• AD/PD involve dysfunction through protein-protein interaction disruption
• Both converge on impaired SNARE complex function but via different mechanisms

Protein-Protein Interactions

Core SNARE Complex

VAMP2's most important interactions are within the SNARE complex[@sutton1998]:

| Partner | Interaction Type | Functional Effect |
|---------|----------------|-------------------|
| SNAP-25 | SNARE complex (v-SNARE) | Forms ternary complex for fusion |
| Syntaxin-1A | SNARE complex (binary R-SNARE) | Initial docking and assembly |
| Synaptotagmin-1 | Ca²⁺-dependent regulation | Triggers fusion upon Ca²⁺ influx |
| Complexin | SNARE complex stabilizer | Regulates release probability |

Alpha-Synuclein and Parkinson's

[Alpha-synuclein](/proteins/alpha-synuclein) is the most disease-relevant VAMP2 interactor[@burre2010]:

• α-Syn C-terminal binds VAMP2 at the SNARE motif
• This competes with syntaxin-1 for VAMP2 binding
• Oligomeric α-Syn is particularly potent at inhibiting VAMP2 function
• The interaction is reversible — reducing α-Syn restores VAMP2 function

Trafficking Regulators

| Interactor | Interaction Type | Effect |
|------------|----------------|--------|
| Dynamin-1/3 | Endocytosis | Vesicle scission after fusion |
| Synaptojanin-1 | PI(4,5)P₂ hydrolysis | Vesicle retrieval and recycling |
| NSF (ATPase) | SNARE disassembly | Recycles SNARE proteins post-fusion |
| α-SNAP | SNARE disassembly | Co-factor for NSF |
| Vps41 | HOPS complex | Autophagosome-lysosome fusion |

Therapeutic Targeting

SNARE Complex Stabilizers

Enhancing VAMP2 incorporation into SNARE complexes is a therapeutic strategy[@shen2015]:

• Rationale: If VAMP2 availability is limiting, stabilizing its interactions could restore synaptic function in AD/PD
• Approach: Small molecules that promote VAMP2-syntaxin-1-SNAP-25 ternary complex formation
• Status: Preclinical — no compounds have advanced to clinical trials

Alpha-Synuclein Pathway Modulation

Targeting the α-Syn-VAMP2 interaction addresses a root cause in PD:

• Anti-α-Syn antibodies: May reduce oligomeric α-Syn that blocks VAMP2
• α-Syn aggregation inhibitors: Reduce the pool of inhibitory species
• Gene therapy: Viral delivery of VAMP2 to restore SNARE complex levels

Gene Therapy Approaches

• AAV-VAMP2: Overexpressing VAMP2 to compensate for α-Syn inhibition
• Neuron-specific promoters: Targeting dopaminergic neurons in PD
• Combination therapy: VAMP2 + other SNARE components (SNAP-25, complexin)

Signaling Pathway

Animal Models

Knockout Mice

• VAMP2 KO: Perinatal lethality, complete loss of fast synchronous release at central synapses
• Conditional KO: Forebrain-specific deletion causes severe learning deficits
• Heterozygous KO: Viable with mild synaptic phenotypes — models human haploinsufficiency

Transgenic and Viral Models

• VAMP2 overexpression: Rescues α-Syn-induced synaptic dysfunction
• VAMP2 point mutants: D(40-50)A mutants impair SNARE complex assembly
• AAV-VAMP2 delivery: Restores dopamine release in PD models

Cross-Links

• [VAMP2 Gene](/genes/vamp2)
• [SNAP-25 Protein](/proteins/snap25)
• [Syntaxin-1A Protein](/proteins/stx1a-protein)
• [Synaptotagmin-1 Protein](/proteins/syt1-protein)
• [Alpha-Synuclein Protein](/proteins/alpha-synuclein)
• [Amyloid-Beta Protein](/proteins/amyloid-beta)
• [SNARE Complex](/proteins/snare-complex)
• [Synaptic Vesicle Cycle](cell-types/synaptic-vesicle-cycle)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [UniProt: VAMP2 (P63027)](https://www.uniprot.org/uniprot/P63027)
• [PDB: VAMP2 Structures](https://www.rcsb.org/search?q=VAMP2)
• [NCBI Gene: VAMP2](https://www.ncbi.nlm.nih.gov/gene/6844)
• [Allen Brain Atlas: VAMP2 Expression](https://human.brain-map.org/microarray/search/show?search_term=VAMP2)